Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to 7.92%.

  • Tandem Diabetes Care's EBITDA Margin fell 4900.0% to 7.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.07%, marking a year-over-year decrease of 59400.0%. This contributed to the annual value of 10.57% for FY2024, which is 187800.0% up from last year.
  • Tandem Diabetes Care's EBITDA Margin amounted to 7.92% in Q3 2025, which was down 4900.0% from 20.25% recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's EBITDA Margin peaked at 4.85% during Q4 2021, and registered a low of 72.11% during Q1 2023.
  • Over the past 5 years, Tandem Diabetes Care's median EBITDA Margin value was 9.76% (recorded in 2022), while the average stood at 15.45%.
  • Per our database at Business Quant, Tandem Diabetes Care's EBITDA Margin crashed by -623600bps in 2023 and then soared by 486300bps in 2024.
  • Tandem Diabetes Care's EBITDA Margin (Quarter) stood at 4.85% in 2021, then tumbled by -218bps to 5.72% in 2022, then crashed by -135bps to 13.43% in 2023, then soared by 87bps to 1.79% in 2024, then plummeted by -342bps to 7.92% in 2025.
  • Its EBITDA Margin was 7.92% in Q3 2025, compared to 20.25% in Q2 2025 and 54.83% in Q1 2025.